Discovering and validating effective drugs to manage arthropod-borne diseases (ABD) is a timely and important research challenge with major impacts on real-world control programs at the time of quick resistance development in the targeted pathogens. This editorial highlights major research advances in the development of drugs for the control of vector-borne diseases, with a significant focus on malaria, Chagas disease, dengue, human African trypanosomiasis, leishmaniasis, and Zika. Broad reviews providing new insights on ABD recently published in Molecules have also been covered in "The Editors' pick" section.
Keywords: Chagas disease; Japanese encephalitis; West Nile fever; Zika virus; chikungunya; dengue; human African trypanosomiasis; leishmaniasis; lymphatic filariasis; malaria; yellow fever.